Beclometasone, Formeterol and Glycopyrronium (Trimbow®) (Other inhalers)
Triple dose inhaler available as a pressurised metered dose inhaler delivering a solution with a nominal dose per actuation of 87 micrograms beclometasone dipropionate, 5 micrograms formoterol fumarate dihydrate and 9 micrograms glycopyrronium
Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 92 micrograms fluticasone furoate, 65 micrograms umeclidinium bromide equivalent to 55 micrograms umeclidinium and 22 micrograms vilanterol (as trifenatate). This corresponds to a pre-dispensed dose of 100 micrograms fluticasone furoate, 74.2 micrograms umeclidinium bromide equivalent to 62.5 micrograms umeclidinium and 25 micrograms vilanterol (as trifenatate).
Fluticasone propionate and formoterol (Flutiform®)
children between 12-18 where sirdupla is not licenced
Fluticasone propionate and salmeterol (AirFluSal Forspiro® )
Fluticasone propionate and salmeterol (Sirdupla®, Seretide®)
Seretide 50 Evohaler * Paediatric use only
Seretide Evohaler and Accuhaler. Restricted to use in asthma not to be used as new initiation for COPD
Green -Medicines suitable for routine use within primary care and Secondary care
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies
Amber- Medicines suitable to be prescribed in primary care after specialist /Consultant recommendation or initiation.
A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust Medicines and Therapeutic Committee and approved by the Area Prescribing Committee.
Red-Hospital initiation and continuation only
AMBER SHARE CARE PROTOCOL- Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised
To be supplied from the appropriate commissioned provider.
GREEN 2- to be prescribed by primary care only
GREY- NON FORMULARY (As agreed by Area Prescribing Committee)